Global Lyme Alliance (GLA) is dedicated to accelerating the development of more effective methods of diagnosis and treatment of Lyme and other tick-borne diseases. The urgency of our research mission is greater than ever before.
GLA’s world-class Scientific Advisory Board awards research grants following guidelines established by the National Institutes of Health (NIH). Funds raised support researchers at accredited universities conducting evidence-based research. Learn about our funded research.
GLA's Director of Research and Science, Dr. Mayla Hsu, discusses findings by Dr. Shannon Delaney, who suggests that Borrelia miyamotoi is an infectious trigger for chronic illness, closely resembling Lyme disease.
Tens of thousands of people in the U.S. have lingering illness following COVID-19, known as post-Covid “long haulers.” Why do some people recover relatively quickly from Lyme disease and Covid-19, and a significant number do not?
- Philanthropist and animal rights activist Marisol Thomas